Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
B
Bum‐Kee Hong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
245
Papers
9.3K
Citations
33
h-index
93
i10-index
Bum‐Kee Hong is an academic researcher from Yonsei University. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Cardiac Imaging and Diagnostics & Lipoproteins and Cardiovascular Health. The author has an h-index of 33, co-authored 209 publications.
ORCID: 0000-0002-6456-0184Papers by this author
worksA New Strategy for Discontinuation of Dual Antiplatelet Therapy
2012 · Journal of the American College of Cardiology · 637 citations
https://doi.org/10.1016/j.jacc.2012.06.043
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Effect of Intravascular Ultrasound–Guided vs Angiography-Guided Everolimus-Eluting Stent Implantation
2015 · JAMA · 578 citations
https://doi.org/10.1001/jama.2015.15454
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
2020 · JAMA · 524 citations
https://doi.org/10.1001/jama.2020.7580
Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage)
2012 · Journal of clinical lipidology · 75 citations
https://doi.org/10.1016/j.jacl.2012.01.009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat